Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suis

• Published in: Pathogens (Basel) 2020-05, Vol.9 (5), p.374-39
• Main Authors: Segura, Mariela, Aragon, Virginia, Brockmeier, Susan L, Gebhart, Connie, Greeff, Astrid de, Kerdsin, Anusak, O'Dea, Mark A, Okura, Masatoshi, Saléry, Mariette, Schultsz, Constance, Valentin-Weigand, Peter, Weinert, Lucy A, Wells, Jerry M, Gottschalk, Marcelo
• Format: Article
• Language: English
• Subjects: Animal biology; Antigens; Antimicrobial agents; Antimicrobial resistance; Cloning; Conference Report; diagnosis; Drug resistance; Economic impact; Epidemics; Epidemiology; Genomes; genomics; Hogs; Impact analysis; Infections; Life Sciences; Livestock; Meat; Pathogenesis; Pathogens; Phylogenetics; Pork; Prevention; Public health; Quality control; Streptococcus suis; Swine; Swine production; Vaccines; Veterinary medicine; Veterinary medicine and animal Health; Workshops; Zoonoses; zoonosis
• ISSN: 2076-0817; 2076-0817
• DOI: 10.3390/pathogens9050374

is a swine pathogen and a zoonotic agent afflicting people in close contact with infected pigs or pork meat. Sporadic cases of human infections have been reported worldwide. In addition, outbreaks emerged in Asia, making this bacterium a primary health concern in this part of the globe. In pigs, disease results in decreased performance and increased mortality, which have a significant economic impact on swine production worldwide. Facing the new regulations in preventive use of antimicrobials in livestock and lack of effective vaccines, control of infections is worrisome. Increasing and sharing of knowledge on this pathogen is of utmost importance. As such, the pathogenesis and epidemiology of the infection, antimicrobial resistance, progress on diagnosis, prevention, and control were among the topics discussed during the 4th International Workshop on (held in Montreal, Canada, June 2019). This review gathers together recent findings on this important pathogen from lectures performed by lead researchers from several countries including Australia, Canada, France, Germany, Japan, Spain, Thailand, The Netherlands, UK, and USA. Finally, policies and recommendations for the manufacture, quality control, and use of inactivated autogenous vaccines are addressed to advance this important field in veterinary medicine.